- In November 2023, J&J's MONARCH Platform became the first minimally invasive, robotic-assisted technology approved for bronchoscopy in China, where the burden of lung cancer is significant. This approval highlights the growing demand for advanced surgical tools in oncology
- In February 2023, Stryker’s Q Guidance System received US FDA clearance for supporting cranial surgeries, making it a key tool for enhancing precision in cranial procedures. This clearance paves the way for broader adoption of robotic guidance in neurosurgery
- In January 2023, PENTAX Medical obtained CE marks for its PENTAX Medical INSPIRA, a new premium video processor, and the i20c video endoscope series. This new generation of video endoscopes sets new standards while maintaining compatibility with recent endoscope models
- In June 2022, Boston Scientific entered into a deal with South Korea’s Synergy Innovation to acquire a majority stake in M.I.Tech, a company specializing in the manufacturing and distribution of non-vascular metal stents for endoscopic and urologic procedures. This strategic acquisition enhances Boston Scientific's portfolio in minimally invasive treatments
- In August 2022, Sight Sciences, Inc. announced the launch of SION, a surgical instrument designed to remove trabecular meshwork in ocular surgeries. SION is engineered with specialized lasers that allow tissue excision without cutting, offering a precise, continuous motion for surgeons. This launch enhances Sight Sciences' offering in ocular surgery innovations
